Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. BT8009-230

   BICYCLE THERAPEUTICS

   Locally advanced or metastatic urothelial cancer

   phase 3 · small molecule · active

   1 trial →

2. BT8009-230

   BICYCLE THERAPEUTICS

   Locally advanced or metastatic urothelial cancer

   phase 3 · small molecule · active

   1 trial →

3. BX44273

   Hoffmann-La Roche

   This is an extension study designed to provide continued treatment for eligible patients with cancer who were previously enrolled and treated in a Genentech/Roche study (the parent study), and do not have access to the treatment locally

   phase 3 · small molecule · active

   1 trial →

4. Bacillus Calmette Guerin and interferon alpha

   Hospital Authority, Hong Kong

   Carcinoma of Urinary Bladder, Superficial

   phase 3 · small molecule · completed

   1 trial →

5. Bavencio 20 mg/mL concentrate for solution for infusion

   Merck Sharp and Dohme

   Solid Tumors

   phase 3 · small molecule · active

   1 trial →

6. Bel-sar

   Aura Biosciences

   Choroidal Melanoma

   phase 3 · small molecule · active

   1 trial →

7. Bempegaldesleukin

   Nektar Therapeutics UK Limited

   Melanoma

   phase 3 · mab · terminated

   1 trial →

8. Bempegaldesleukin

   Nektar Therapeutics UK Limited

   Metastatic Head and Neck Cancer

   phase 3 · small molecule · terminated

   1 trial →

9. Bendamustine

   Hoffmann-La Roche

   Chronic Lymphocytic Leukemia

   phase 3 · small molecule · completed

   1 trial →

10. Bendamustine HCl

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 3 · small molecule · completed

    1 trial →

11. Bendamustine hydrochloride

    Teva Pharma GmbH

    Non-Hodgkin Lymphoma

    phase 3 · small molecule · completed

    1 trial →

12. Bevacizumab

    Hoffmann-La Roche

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

13. Bevacizumab

    Samsung Bioepis NL B.V.

    Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

14. Bevacizumab

    Hoffmann-La Roche

    B-cell Lymphoma

    phase 3 · small molecule · terminated

    1 trial →

15. Bevacizumab

    Pfizer

    Renal Cell Carcinoma

    phase 3 · small molecule · completed

    1 trial →

16. Bevacizumab-Pfizer

    Pfizer

    Non-Small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

17. Bosutinib

    Pfizer

    Chronic Myeloid Leukemia

    phase 3 · small molecule · completed

    1 trial →

18. Brentuximab Vedotin

    Takeda

    Primary Cutaneous Anaplastic Large Cell Lymphoma

    phase 3 · small molecule · completed

    1 trial →

19. Brentuximab Vedotin for Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Classical Hodgkin Lymphoma

    phase 3 · small molecule · active

    1 trial →

20. Brentuximab vedotin

    Takeda

    Diffuse Large B-cell-lymphoma

    phase 3 · small molecule · active

    1 trial →

21. Brentuximab vedotin

    Pfizer

    Diffuse Large B-cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

22. Brigimadlin

    Boehringer Ingelheim

    Liposarcoma, Dedifferentiated

    phase 3 · small molecule · completed

    1 trial →

23. Bupivacaine

    Pacira Ireland Limited

    Malignant Neoplasms of Female Genital Organs

    phase 3 · small molecule · terminated

    1 trial →

24. Busulfan (BU)

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma

    phase 3 · small molecule · active

    1 trial →

25. C16-40

    The George Institute

    Unresectable locally advanced and/or metastatic soft-tissue sarcoma

    phase 3 · small molecule · active

    1 trial →

26. C2321003

    Pfizer Australia Pty Ltd

    METASTATIC CASTRATION RESISTANT PROSTATE CANCER

    phase 3 · small molecule · active

    1 trial →

27. C2321008

    Pfizer Australia Pty Ltd

    METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

    phase 3 · small molecule · active

    1 trial →

28. C2321014

    Pfizer Australia Pty Ltd

    METASTATIC CASTRATION RESISTANT PROSTATE CANCER

    phase 3 · small molecule · active

    1 trial →

29. C25003

    Takeda

    Advanced Classical Hodgkin Lymphoma

    phase 3 · small molecule · active

    1 trial →

30. C3441021

    Pfizer Australia Pty Ltd

    Metastatic Castration-resistant Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

31. C3441052

    Pfizer Australia Pty Ltd

    Metastatic Castration-sensitive Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

32. C3651021

    Pfizer Australia Pty Ltd

    Cancer cachexia

    phase 3 · small molecule · active

    1 trial →

33. C4221015

    Pfizer Australia Pty Ltd

    Colorectal cancer (BRAF V600E-mutant mCRC)

    phase 3 · small molecule · active

    1 trial →

34. C4221016

    Pfizer Australia Pty Ltd

    Metastatic or unresectable locally advanced BRAF V600E/K mutation positive melanoma

    phase 3 · small molecule · active

    1 trial →

35. C4391022

    Pfizer Australia Pty Ltd

    Hormone receptor-positive, her2-negative advanced/metastatic breast cancer

    phase 3 · small molecule · active

    1 trial →

36. C4391024

    Pfizer Australia Pty Ltd

    Advanced/Metastatic Breast Cancer

    phase 3 · small molecule · active

    1 trial →

37. C4551002

    Pfizer Australia Pty Ltd

    Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

    phase 3 · small molecule · active

    1 trial →

38. C5751003

    Pfizer Australia Pty Ltd

    non-small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

39. C6461001

    Pfizer Australia Pty Ltd

    LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER

    phase 3 · small molecule · active

    1 trial →

40. C6461003

    Pfizer Australia Pty Ltd

    Metastatic Colorectal Cancer

    phase 3 · small molecule · active

    1 trial →

41. C6461004

    Pfizer Australia Pty Ltd

    Extensive-Stage Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

42. CA017-078

    Bristol-Myers Squibb Australia Pty Ltd

    Bladder Cancer Muscle-Invasive Bladder Cancer

    phase 3 · small molecule · active

    1 trial →

43. CA071-1000

    Celgene Europe Limited

    Metastatic Castration-resistant Prostate Cancer (mCRPC)

    phase 3 · small molecule · active

    1 trial →

44. CA073-1003

    Celgene Europe Limited

    Relapsed/Refractory Follicular Lymphoma

    phase 3 · small molecule · active

    1 trial →

45. CA073-1020

    Celgene Europe Limited

    High-risk Large B-cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

46. CA127-1030

    Bristol-Myers Squibb Australia Pty Ltd

    Non small cell lung cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

47. CA209-577

    Bristol-Myers Squibb Australia Pty Ltd

    Subjects with resected adenocarcinoma or squamous cell carcinoma esophageal or gastroesophageal junction cancer

    phase 3 · small molecule · active

    1 trial →

48. CA209-67T

    Bristol-Myers Squibb Australia Pty Ltd

    Metastatic Clear Cell Renal Cell Carcinoma

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions